Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome

Completed · Not applicable · Has a placebo group

Conditions studied: Fragile X-Associated Tremor/Ataxia Syndrome, Fragile X Premutation Carriers

In brief

The purpose of this study is to determine if memantine is effective in treating symptoms of Fragile X-associated Tremor Ataxia Syndrome.

Key facts

Study ID

NCT00584948

Run by

University of California, Davis

People needed

94

Starts

2007-09-01

Expected to finish

2012-09-01

Last updated by the study team

2017-05-30

Who can join

Age: 30 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Fragile X premutation carrier (CGG repeat 55-200)with neurological symptoms; Clinical FXTAS Stage 1-5

You may not qualify if…

• Previous reaction to memantine

Where it is running

• UC Davis MIND Institute — Sacramento, California, United States
• University of Colorado Health Sciences Center — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.